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Abstract
Background: The aim of this study was to evaluate factors associated with increased risk of mortality from
pneumonia among patients with pneumoconiosis.
Methods: Medical records of 103 pneumoconiosis patients hospitalized for pneumonia were investigated. Seven
patients who had lung cancer or other malignancy and 13 patients with insufficient medical record were excluded.
Two female patients were excluded due to small number to analyze. The subjects were divided into two groups by
clinical outcome of pneumonia, the deceased group and the survival group. The two groups were compared in
terms of age, smoking history, episode of recent pneumonia, concomitancy of interstitial fibrosis or fungal ball
infection, extent of small opacities, grade of large opacities and results of spirometry. Multiple logistic regression
was applied to determine the association between these variables and mortality from pneumonia.
Results: The deceased group showed more frequent history of recent pneumonia (p = 0.006), higher prevalence of
interstitial fibrosis (p = 0.007) and longer hospitalization period (p = 0.044). The proportion of subjects who had
decreased FVC, less than 70 % of predicted value, was higher in the deceased group (p < 0.001). In multiple logistic
regression, after adjusting age, smoking history, recent pneumonia, fungal ball, large opacity, profusion and FVC (or
FEV1) less than 70 % of predicted value, history of recent pneumonia, concomitancy of interstitial fibrosis, type of
pneumoconiosis and fungal ball presented statistically significant association with mortality from pneumonia.
Conclusions: The concomitancy of fungal ball or interstitial fibrosis, history of recent pneumonia within last
90 days, type of pneumoconiosis, FVC less than 70 % of predicted value, FEV1 less than 70 % of predicted value
presented statistically significant association with mortality from pneumonia. More attention should be given to
patients who have such factors when treating pneumonia with pneumoconiosis.
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Background
Studies on natural history or survival analyses of patients
with pneumoconiosis have been constantly carried out dur-
ing the past several decades [1–8]. There is controversy be-
tween several prognostic factors and its outcomes, however,
the decreased pulmonary function [1, 2], radiographic find-
ings of pneumoconiosis (such as higher grade of profusions
or large opacities in accordance with International Labor
Organization (ILO) classification) [3–7], smoking [8] and
tuberculosis [4] is well known risk factors for progression
to death among patients with pneumoconiosis.
Pneumonia is one of the most common disease entities
that requires hospitalization and eventually leads to death
among pneumoconiosis patients and others suffering from
chronic respiratory diseases [9]. Under the ‘Enforcement
Regulation of Classification and Examination of Pneumo-
coniosis Act’ in Korea, an investigation is carried out on
the occasion of pneumoconiosis patient’s death to assess
the causal relationship between the cause of death and
pneumoconiosis. Accordingly, it is important to determine
factors that contribute to death from pneumonia among
these patients. To date, there have been several studies
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concerning various factors associated with pneumonia-
mortality among patients with underlying pulmonary con-
ditions such as chronic obstructive pulmonary disease
(COPD) or interstitial lung disease [10–13]. However, for
patients with pneumoconiosis, little is known about
pneumonia-specific mortality since prior studies generally
focused on epidemiologic outcomes just as the risk of
all-cause mortality [3–5, 7, 8]. Owing to insufficient
knowledge, when conducting an advisory investigation
regarding causal relationship between mortality from
pneumonia and pneumoconiosis, references have been
commonly made to studies based on other chronic
respiratory diseases mainly with COPD.
Considerable number of patients with pneumoconi-
osis die from pneumonia in Korea, yet, hardly any
study was carried out to assess the risk factors associ-
ated with their deaths. Therefore, the aim of this
study was to analyze factors associated with increas-
ing the risk of mortality from pneumonia among pa-
tients with pneumoconiosis.
Methods
Data source and study population
The present study was performed by reviewing medical
administration records of patients with pneumoconiosis
who were hospitalized with pneumonia between August
1, 2011 and September 10, 2014, at the Department of
Occupational and Environmental Medicine of Seoul St.
Mary’s Hospital. Whole participants have been compen-
sated for pneumoconiosis and registered at Korea Worker’s
Compensation and Welfare Service by recorded working
history and confirmed radiologic exam. Inclusion criteria
was hospitalization of these patients due to pneumo-
nia (n = 103). Exclusion Criteria were lung cancer (n = 7)
or other malignancy and lack of data in medical records
(n = 12). Patients who underwent cancer surgery was
not excluded if there was no evidence of recurred or
ongoing malignancy after the operation. Female pa-
tients (n = 2) were excluded due to small number of
subjects to analyze. The number of final eligible sub-
jects was 82.
Case definition
With regard to inclusion criteria, patients hospitalized
for pneumonia during the referred period were consid-
ered. Diagnosis as pneumonia was done by medical
examination, blood tests and radiologic exam. In the
medical record, ICD (International Classification of Dis-
eases)-10-code J12x, J13x, J15x, J17x, J18x were counted
as pneumonia. The participants were divided into two
groups by clinical outcome of pneumonia as follows; the
patients who survived pneumonia and the others pa-
tients who died from pneumonia.
Radiologic findings of subjects
Radiographic progression of pneumoconiosis was assessed
according to International Labor Organization (ILO)
classification [14]. The extent of small opacities was cate-
gorized into profusion score (1, 2 or 3) based on a three-
point scale. Large opacities, exceeding width of 10 mm,
were classified into either A, B or C. The classifica-
tion of large opacities A cover those of which longest
dimension up to 50 mm or several large opacities
with the sum of their longest dimension. Large opacities
exceeding width of 50 mm but not exceeding the equiva-
lent area of the right upper lung (RUL) zone was classified
as B. If the sum of size of large opacities exceeded equiva-
lent area of RUL zone, it was classified as C.
Whether the patient had fungal ball infection or
interstitial lung fibrosis was also determined. Fungal
ball infection was confirmed with sputum culture
and computed tomography (CT) of the chest. Exist-
ence of concomitant interstitial lung fibrosis with
pneumoconiosis was acknowledged only when the
chest CT showed either a finding of interstitial lung
disease (ILD), interstitial pulmonary fibrosis (IPF),
non-specific interstitial fibrosis or fibrotic type
pneumoconiosis.
Demographic and clinical characteristics
Each patients’ general and clinical characteristics includ-
ing age at the diagnosis of pneumonia, smoking history,
results of spirometry and episodes of recent pneumonia
were reviewed and assessed. Recent pneumonia was de-
fined as history of recent hospitalization with pneumonia
in 90 days from the last day of hospitalization with
pneumonia. In addition, type of pneumoconiosis was
taken into account depending upon the type of sus-
pected dust which subjects had been exposed to. All of
subjects were classified as either silicosis or coal worker’s
pneumoconiosis (CWP). There was no patient who was
suspicious of asbestosis or other type of pneumoconiosis
based on occupational history.
The results values of the latest spirometry before the
case of pneumonia was used for the analysis. In spirom-
etry, the percentage values of predicted forced expiratory
volume in one second (FEV1 % =measured FEV1/refer-
ence FEV1), forced vital capacity (FVC % =measured
FVC/reference FVC) and FEV1-FVC ratio (FEV1/FVC)
were checked. The reference values were calculated using
Choi Jung-Keun equation [15]. Licensed and trained tech-
nicians performed the test using a dry rolling seal spirom-
eter (model 2130; SensorMedics, Yorba Linda, CA, USA).
The quality-control program was fulfilled under calibra-
tion and complying with the American Thoracic Society/
European Respiratory Society criteria of acceptability and
repeatability of the spirometry [16].
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Statistical analysis
The two groups were compared in terms of demo-
graphic, radiologic and clinicopathological variables.
Continuous variables including age, smoking history as
pack-years (number of packs smoked per days multiplied
by the number of years as a smoker) and the measured
values of spirometry followed normal distributions and
they were compared between the two groups using stu-
dent t-test. Chi-square test was used to analyze the dif-
ferences in history of recent pneumonia, extent of small
opacities, grade of large opacities and presence of inter-
stitial fibrosis or fungal ball infection between two
groups. Fisher’s exact test was performed to evaluate dif-
ferences for factors including FEV1 less than 70 % of
predicted value, FVC less than 70 % of predicted value,
type of pneumoconiosis and concomitancy of fungal ball.
In multiple logistic regression analysis, age, smoking his-
tory, episode of recent pneumonia, concomitancy of
interstitial fibrosis or fungal ball infection, extent of
small opacities, grade of large opacities, type of pneumo-
coniosis and results of spirometry (FEV1 % or FVC %)
were adjusted.
Statistical Analysis System (SAS) version 9.3 (SAS
Institute, Cary, NC, USA) was used to analyze the data.
The ethical issues of the study was approved by the
Institutional Review Board Seoul St. Mary’s Hospital (ID:
KC14RISI0831).
Results
Table 1 describes general characteristics of the subjects
and the differences between the two groups. Mean
values are presented in bold type with standard deviation
following ±mark. Categorical values are presented with
number of the case followed by percentage in brackets.
The total mean age of the patients was 71.0 ± 7.2 years.
Sixty-two patients were ex-smokers and four patients
were current-smoker. Comparing with the survival
group, the deceased group showed statistically signifi-
cant decrease in FEV1 % and FVC %. Those who experi-
enced recent pneumonia in the preceding three months
were more likely to expire from pneumonia. Also, there
were more frequent presence of interstitial fibrosis or
fungal ball infection in the deceased group.
Table 2 summarize the results of logistic regression
analysis. The crude ORs for recent pneumonia, intersti-
tial fibrosis and FVC less than 70 % of predicted value
were 4.09 (95 % CI 1.46-11.95), 4.75 (95 % CI 1.46-
15.99) and 6.60 (95 % CI 1.70-43.75), respectively. In
Model 1, adjusting for age, smoking history, recent
pneumonia, interstitial fibrosis, fungal ball, type of
pneumoconiosis, large opacity, profusion and FVC less
than 70 % of predicted, ORs for recent pneumonia,
interstitial fibrosis, fungal ball, CWP and FVC less than
70 % of predicted value were 6.33 (95 % CI 1.52-31.12),
6.50 (95 % CI 1.41-35.82), 73.44 (95 % CI 3.69- > 999.99),
7.59 (95 % CI 1.19-74.73) and 16.86 (95 % CI 1.19-
74.73), respectively. In Model 2, age, smoking history,
recent pneumonia, interstitial fibrosis, type of pneumo-
coniosis, fungal ball, large opacity, profusion and FEV1
less than 70 % of predicted were adjusted. Statistically
significant risk elevation of pneumonia-mortality was de-
tected in history of recent pneumonia (OR 6.47, 95 % CI
1.64-29.99), interstitial fibrosis (OR 8.91, 95 % CI 1.95-
52.63), fungal ball (OR 13.75, 95 % CI 1.30-210.44) and
CWP (OR 7.76, 95 % CI 1.21-79.15). FEV1 less than
70 % of predicted value also showed elevated OR of
10.95 (95 % CI 1.11-302.02).
Discussion
In the present study, the concomitancy of interstitial fi-
brosis or fungal ball, history of recent pneumonia within
last 90 days, type of pneumoconiosis, FEV1 less than
70 % of predicted value and FVC less than 70 % of
predicted value showed statistically significant positive
associations with pneumonia-mortality.
History of recent pneumonia within last 90 days was
shown to be significantly associated with pneumonia-
mortality in the present study. It is accordant to previous
researches that people who have medical record of
recent admission for pneumonia tends to be re-
hospitalized for pneumonia compared to the others who
don’t [17, 18]. The preceding infection of respiratory
tract has long been suspected as a predisposing factor
for pneumonia [19]. The present study adds a concept
that recent admission for pneumonia is not only associ-
ated with subsequent re-hospitalization for pneumonia
but also with poor clinical outcome of pneumonia as
well. Patients with pneumoconiosis commonly get pneu-
monia, and frequent occur of pneumonia may imply
more likelihood of death from it. To confirm, further
studies should be followed to determine factors associ-
ated with frequent occurrence of pneumonia.
The host defense system acts against respiratory path-
ogens to prevent occurrence of lung infection and
defense agents such as macrophage, lymphocytes and
mucociliary cells play a key role in the respiratory
defense mechanism [17, 20, 21]. However, such respira-
tory defense system seems to be deteriorated among the
patients with pneumoconiosis. According to previous
studies, alveolar macrophages are directly damaged by
silica or coal dust particles, followed by diverse inflam-
matory cytokines and free radicals derived directly from
coal mine dust and indirectly from involved leukocytes
[22, 23]. Subsequently, these reactions trigger fibrosis
and impairment of lymphatic drainage of the lung.
Therefore, it is hard to expect well-functioning defense
mechanism from the lung of patients with pneumoconi-
osis. Aspergillus related lung disease is well known to be
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Table 1 Demographic and clinical features of the study population
Total Clinical outcome
Survival Decease p-value
Age 71.0 ± 7.2 71.4 ± 7.1 70.0 ± 7.4 0.456
50–59 5 (8.2 %) 1 (4.8 %)
60–69 14 (23.0 %) 10 (47.6 %)
70–79 39 (63.9 %) 8 (38.1 %)
Over 80 3 (4.9 %) 2 (9.5 %) 0.119
Smoking history
Pack-yearsa 18.0 ± 18.1 15.9 ± 16.9 24.2 ± 20.3 0.068
Never smoker 14 (23.0 %) 2 (9.5 %)
Previous smoker 44 (72.1 %) 18 (85.7 %)
Current smoker 3 (4.9 %) 1 (4.8 %) 0.401
Pneumoconiosis characteristicsb
Profusion of small opacity
1 15 (24.6 %) 2 (9.5 %)
2 37 (60.7 %) 13 (62.0 %)
3 9 (14.8 %) 6 (28.6 %) 0.188
Grade of large opacity
No 17 (27.9 %) 3 (14.3 %)
A 8 (13.1 %) 4 (19.0 %)
B 22 (36.1 %) 10 (47.6 %)
C 14 (23.0 %) 4 (19.0 %) 0.532
Pulmonary function profiles
FEV1 % predicted 50.9 ± 20.6 53.6 ± 22.1 43.1 ± 13.4 0.012
70 ≤ 13 (21.3 %) 1 (4.8 %)
< 70 48 (78.7 %) 20 (95.2 %) 0.102
FVC % predicted 63.4 ± 17.7 66.9 ± 18.1 53.4 ± 11.9 <0.001
70 ≤ 25 (40.9 %) 2 (9.5 %)
< 70 36 (59.0 %) 19 (90.5 %) 0.008
FEV1/FVC ratio 58.3 ± 18.4 57.8 ± 18.0 59.9 ± 19.9 0.648
70 ≤ 19 (31.1 %) 8 (38.1 %)
< 70 42 (68.9 %) 13 (61.9 %) 0.559
Type of pneumoconiosis
silicosis 14 (22.9 %) 3 (14.3 %)
CWPc 47 (77.1 %) 18 (85.7 %) 0.839
Recent pneumoniad
No 46 (75.4 %) 9 (42.9 %)
Yes 15 (24.6 %) 12 (57.1 %) 0.006
Interstitial fibrosise
No 54 (88.5 %) 13 (61.9%)
Yes 7 (11.5 %) 8 (38.1 %) 0.007
Fungal ballf
No 59 (96.7 %) 18 (85.7 %)
Yes 2 (3.3 %) 3 (14.3 %) 0.103
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found in immunocompromised patients and tends to
form mycelial balls in the lungs where the local
defense mechanism is impaired with preexisting pul-
monary disease [24–27]. In patients with complicated
pneumoconiosis, central cavitation of progressive
massive fibrosis often occurs due to ischemic necrosis
or other conditions [28]. Development of fungal ball
in this cavitary lesion can be source of hemoptysis or
pulmonary infection when involved with invasive as-
pergillosis [26]. Therefore, the presence of fungal ball
Table 1 Demographic and clinical features of the study population (Continued)
Hospitalized days 14.8 ± 13.5 13.0 ± 13.4 19.9 ± 13.0 0.044
Total 82 (100 %) 61 (74.4 %) 21 (25.6 %)
Mean values are shown in bold type with standard deviation following ± mark. Categorical values are presented with number of the case followed by percentage
in brackets
aPack-years: Pack-years of never smokers were counted as 0
bPneumoconiosis characteristics: Radiographic findings assessed in accordance with ILO classification
cCWP : Coal worker’s pneumoconiosis
dRecent pneumonia: History of recent hospitalization due to pneumonia within 90 days from the last day of hospitalization with pneumonia
eInterstitial fibrosis: Presence of interstitial fibrosis confirmed by findings of chest CT including ILD, IPF, non-specific interstitial fibrosis or fibrotic type pneumoconiosis
fFungal ball: Concomitancy of fungal ball infection confirmed by sputum culture and chest CT
Table 2 Factors associated with pneumonia-mortality among subjects
Unadjusted model Model 1 Model 2
OR 95 % CI OR 95 % CI OR 95 % CI
Age (per year) 0.97 0.91-1.04 0.98 0.89-1.08 0.99 0.91-1.09
Smoking (pack-years) 1.03 0.99-1.05 1.03 0.99-1.07 1.03 0.99-1.07
Recent pneumonia
No 1.00 1.00 1.00
Yes 4.09 1.46-11.95 6.33 1.52-31.12 6.47 1.64-29.99
Interstitial fibrosis
No 1.00 1.00 1.00
Yes 4.75 1.46-15.99 6.50 1.41-35.82 8.91 1.95-52.63
Fungal ball
No 1.00 1.00 1.00
Yes 4.92 0.76-39.58 73.44 3.69- > 999.99 28.47 2.18-654.13
Type of pneumoconiosis
Silicosis 1.00 1.00 1.00
CWP 1.79 0.51-8.41 7.59 1.19-74.73 7.76 1.21-79.15
Large opacity
No 1.00 1.00 1.00
A or B or C 2.32 0.67-10.79 3.07 0.46-30.23 1.99 0.33-15.20
Profusion
1 1.00 1.00 1.00
2 2.64 0.63-18.16 1.32 0.15-15.47 1.04 0.12-12.28
3 5.00 0.93-39.49 1.83 0.17-26.28 1.93 0.18-28.08
FEV1 predicted (%)
≥ 70 1.00 NA 1.00
< 70 5.42 0.98-101.65 NA 10.95 1.11-302.02
FVC predicted (%)
≥ 70 1.00 1.00 NA
< 70 6.60 1.71-43.75 16.86 1.19-74.73 NA
Statistically significant values are shown in bold type
Model 1: Adjustment for age, smoking history, recent pneumonia, fungal ball, type of dust, large opacity, profusion and FVC less than 70 % of predicted
Model 2: Adjustment for age, smoking history, recent pneumonia, fungal ball, type of dust, large opacity, profusion and FEV1 less than 70 % of predicted
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on Chest CT may indicate impaired respiratory defense
mechanism of the patient with pneumoconiosis and lead
to poor clinical course concerning pneumonia.
Despite showing statistically non-significant associ-
ation in its simple regression analysis, type of pneumo-
coniosis (CWP versus silicosis) presented significantly
increased odd ratio in both Model 1 and Model 2. There
is few study concerning the difference in outcome of a
pneumonia course between those diagnosed with CWP
and silicosis. There would be several possible causes for
those differences. In subgroup analysis, mean age of sub-
jects with CWP (71.9 ± 7.3) was significantly higher than
mean age of subjects with silicosis (67.7 ± 5.8) perform-
ing t-test (p-value = 0.03). This inequality may explain
circumstances which led to higher mortality of subjects
with CWP, though age was adjusted in Model 1 and
Model 2. In addition, there is possibility of misclassifica-
tion since occupational history was based on self-report.
Still, there is little clue to clarify the correlation between
higher pneumonia-mortality and CWP against silicosis.
Accordingly, further study with proper design is required
to investigate association between types of pneumoconi-
osis and pneumonia-mortality.
For the presence of interstitial fibrosis on the chest
CT, we found an elevated risk for poor prognosis. This
results corresponds to the GAP model recently intro-
duced by Ley et al., which is used to predict mortality of
idiopathic pulmonary fibrosis patients [29]. In the GAP
model, multidimensional indices consist of gender(G),
age(A) and 2 lung physiological factors(P) including
FVC, which accounts for two points of total eight pos-
sible points [29]. The less percentage value of predicted
FVC scores higher points, resulting in advanced stage
and prediction of higher mortality [29]. Idiopathic pul-
monary fibrosis generally shows ventilatory dysfunction
with restrictive pattern. Interestingly, FVC less than 70
% of predicted value, which can be interpreted as a pres-
ence of restrictive ventilatory defect, was shown to be
associated with increased mortality from pneumonia. It
seems plausible to assume that pneumoconiosis patients
with decreased baseline lung function and restrictive
ventilatory impairment have disadvantages on the clin-
ical course of pneumonia.
FEV1 less than 70 % of predicted value showed statisti-
cally significant result in Model 2. Decrement in FEV1
indicates lower exercise capacity [30] and higher comor-
bidities and mortality [31] in COPD patients. Loss of
FEV1 may be also related with higher mortality from pneu-
monia among patients with pneumoconiosis. However,
most of subjects in this study did not undergo post-
bronchodilator test on their spirometry, making the value
of FEV1 less reliable. Moreover, FEV1/FVC value could not
be used to determining presence of obstructive ventilator
impairment, or COPD. It is recommended to perform the
test after using an adequate dose of a short-acting inhaled
bronchodilator in order to minimize variability [31]. Due to
retrospective study design, it was not possible to gain the
result of spirometry after administration of a bronchodila-
tor and further analysis or assay was not feasible with
retained records of spirometry. To minimize systematic
error and bias, utilizing post-bronchodilator results of spir-
ometry is needed in further study.
Predicted values of FVC and FEV1 were derived using
Choi Jung-Keun equation [15], however, there is a newer
spirometric reference equation for Korean population
[32]. As a matter of fact, the present ‘Korea worker’s
compensation and welfare service’ is officially recom-
mending Choi Jung-Keun equation for spirometric refer-
ence in worker’s specific examination. This was the main
reason why the antecedent reference equation was ap-
plied despite acknowledging a newer reference equation.
Additional analyses were performed to confirm if there
was any consequence of applying the newer reference
equation. After employing the newer reference equation,
FEV1 less than 70 % of predicted value turned out to be
statistically significant factor in unadjusted model (OR
6.52, 95 % CI 1.19-121.88). It remained statistically sig-
nificant (OR 11.59, 95 % CI 1.17-315.09) after adjusting
other variables in Model 2. FVC less than 70 % of pre-
dicted value remained statistically significant after apply-
ing the newer reference in both unadjusted model (OR
3.55, 95 % CI 1.28-10.62) and Model 2 (OR 12.79, 95 %
CI 2.28-108.46). Notably, other variables such as history
of recent pneumonia, concomitancy of fungal ball and
presence of interstitial fibrosis remained statistically sig-
nificant in both Model 1 and Model 2, regardless of
choice of reference equation.
The major limitations of this study was small number
of participants and single center retrospective design.
However, medical records of every patient with pneumo-
coniosis who admitted with pneumonia was thoroughly
collected and reviewed for the analysis. Additionally,
other pneumonia-mortality predicting variables such as
initial vital sign or blood test indices were not included
in the analysis. Even so, all patients who visited out-
patient clinic or emergency room for pneumonia were
assessed using CURB criteria, to determine the severity
of pneumonia and predict the mortality [33–35]. Pa-
tients with CURB score equal to two or greater were
hospitalized while the others were treated as outpatients.
Following this rule, severities of pneumonia among sub-
jects in this study resulted in less varied. Third, all subjects
were male, owing to small number of female patients.
Since this study was conducted in a single center, these re-
sults may have been affected by selection bias. Therefore,
for confirmation on these findings and clearer assay, fur-
ther multi-centered study with prospective design and con-
sideration of other mortality-predicting factors are needed.
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This is the first exclusive study that analyzed associ-
ation between clinicopathological factors and mortality
from pneumonia among the patients with pneumoconi-
osis in Korea. The findings could help clinicians to cure
pneumonia of patients with pneumoconiosis, by paying
more attention to those who have such proposed factors
associated with pneumonia-mortality. Furthermore, it
could be implemented to investigating whether the cause
of death is related to pneumoconiosis when deciding to
claim compensation in accordance with Enforcement
Regulation of Classification and Examination of Pneumo-
coniosis Act.
Conclusion
The concomitancy of fungal ball or interstitial fibrosis,
history of recent pneumonia within last 90 days, type of
pneumoconiosis, FVC less than 70 % of predicted value,
FEV1 less than 70 % of predicted value presented statisti-
cally significant association with mortality from pneu-
monia. Review of medical history and exams should be
done to detect such factors when treating pneumonia
with pneumoconiosis.
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